Work

Loss-of-function of PBRM1 to predict response to anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.3016

Authors: Diana Miao, Claire Margolis, Dylan Martini, Stephanie Anne Mullane, Dana Cullen, Christine Horak, Megan Wind-Rotolo, Matthew David Hellmann, Martin Henner Voss, Robert J. Motzer, Craig Norton, Sabina Signoretti, Alexandra Snyder Charen, Eliezer Mendel Van Allen, Toni K. Choueiri

Institutions: Dana-Farber Cancer Institute, Bristol-Myers Squibb (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891069722

Cites:

Cited by: 4

Related to: 10